Amerise Biosciences Ltd (AMERISE) is currently trading at 0.63 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Amerise Biosciences Limited was originally incorporated as Amradeep Industries Limited in 1984, specializing in manufacturing construction and agricultural equipment. Initially involved in commodity trading, Amerise shifted to trading castor seeds in 2007, illustrating its adaptability in various market segments. As of the current status, the company is not operational due to a lack of working capital, presenting significant challenges in its operational capabilities. The board is actively looking for opportunities to restart operations, implementing cost reduction measures where possible to maintain financial stability.

Over the past 52 weeks, Amerise Biosciences Ltd has traded between a low of ₹0.51 and a high of ₹1.06. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Amerise Biosciences Ltd has a market capitalization of approximately 4.10. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Amerise Biosciences Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 62.00 and operates in the Finance sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

You can buy shares of Amerise Biosciences Ltd (AMERISE) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.

Based on its market capitalization of 4.10 Cr, Amerise Biosciences Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Amerise Biosciences Ltd operates in the Finance sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Amerise Biosciences Ltd is 62.00. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Amerise Biosciences Ltd currently does not pay dividends. Companies that do not pay dividends often reinvest profits to support business growth or strengthen operations.

Key risks associated with Amerise Biosciences Ltd include sector-specific challenges in the Finance industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.